Some amazing new data presented at #AAD2025. A new #Tyk2 hits #PASI100 in 50% of patients, #Deucravacitinib offers new hope for patients with #lupus and astounding safety and efficacy of #Icotrokinra for #psoriasis.

Details at: www.healio.com/news/dermato...
#DermSky #RheumSky